A Case of Diabetic Keto Acidosis From Alpelisib

Introduction: Alpelisib is a phosphatidylinositol-3-kinase (PI3K) inhibitor, approved for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative, PIK3CA-mutated metastatic breast cancer. While hyperglycemia is a known side effect of this drug, diabetes ketoacid...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Endocr Soc
Asıl Yazarlar: Thumma, Soumya P, Manchala, Venkata R, Motahari, Hooman, Shah, Aashka M, Menon, Lakshmi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2021
Konular:
Diabetes Mellitus and Glucose Metabolism
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089730/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.728
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller